BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15241641)

  • 1. Endothelin receptor antagonists and cerebral vasospasm.
    Zimmermann M; Seifert V
    Clin Auton Res; 2004 Jun; 14(3):143-5. PubMed ID: 15241641
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of endothelin antagonist BQ-610 on cerebral vascular wall following experimental subarachnoid hemorrhage and cerebral vasospasm.
    Cirak B; Kiymaz N; Ari HH; Ugras S
    Clin Auton Res; 2004 Jun; 14(3):197-201. PubMed ID: 15241650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin receptor antagonists and cerebral vasospasm: an update.
    Chow M; Dumont AS; Kassell NF
    Neurosurgery; 2002 Dec; 51(6):1333-41; discussion 1342. PubMed ID: 12445337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of the selective endothelin A (ET(A)) receptor antagonist Clazosentan on cerebral perfusion and cerebral oxygenation following severe subarachnoid hemorrhage - preliminary results from a randomized clinical series.
    Barth M; Capelle HH; Münch E; Thomé C; Fiedler F; Schmiedek P; Vajkoczy P
    Acta Neurochir (Wien); 2007; 149(9):911-8; discussion 918. PubMed ID: 17700991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of endothelin receptor antagonists on vasospasm following aneurysmal subarachnoid hemorrhage.
    Komotar RJ; Starke RM; Connolly ES
    Neurosurgery; 2011 Dec; 69(6):N13-4. PubMed ID: 22067343
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental approaches to evaluate endothelin-A receptor antagonists.
    Vatter H; Zimmermann M; Seifert V; Schilling L
    Methods Find Exp Clin Pharmacol; 2004 May; 26(4):277-86. PubMed ID: 15319806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pathogenesis of cerebral vasospasm after subarachnoid hemorrhage].
    Tamura Y; Ohta T; Ogawa R; Ozaki M; Suyama Y
    No To Shinkei; 2000 Jun; 52(6):461-7. PubMed ID: 10875116
    [No Abstract]   [Full Text] [Related]  

  • 8. [Posthemorrhagic cerebral vasospasm in light of the current concepts on the regulation of cerebral blood circulation].
    Karpiuk VB; Cherniak IuS; Shubin MG
    Zh Vopr Neirokhir Im N N Burdenko; 2000; (1):30-3; discussion 34. PubMed ID: 10738763
    [No Abstract]   [Full Text] [Related]  

  • 9. Endothelin: the "prime suspect" in cerebral vasospasm.
    Zuccarello M
    Acta Neurochir Suppl; 2001; 77():61-5. PubMed ID: 11563310
    [No Abstract]   [Full Text] [Related]  

  • 10. [Perspectives in the treatment of subarachnoid-hemorrhage-induced cerebral vasospasm].
    Fandino J; Fathi AR; Graupner T; Jacob S; Landolt H
    Neurocirugia (Astur); 2007 Feb; 18(1):16-27. PubMed ID: 17393042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral vasospasm after aneurysmal subarachnoid hemorrhage: an overview of pharmacologic management.
    Liu-Deryke X; Rhoney DH
    Pharmacotherapy; 2006 Feb; 26(2):182-203. PubMed ID: 16466324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of endothelin-receptor antagonists on delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage remains unclear.
    Vergouwen MD
    Stroke; 2009 Dec; 40(12):e714; author reply e715-6. PubMed ID: 19875735
    [No Abstract]   [Full Text] [Related]  

  • 13. Vasospasm.
    Dumont AS; Kassell NF
    J Neurosurg; 2005 Jul; 103(1):1-3; discussion 3. PubMed ID: 16121964
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelins and the role of endothelin antagonists in the management of posttraumatic vasospasm.
    Armstead WM
    Curr Pharm Des; 2004; 10(18):2185-92. PubMed ID: 15281894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Systemic treatments of the vasospasm].
    Tavernier B; Decamps F; Vega E; Poidevin P; Verdin M; Riegel B
    Ann Fr Anesth Reanim; 2007 Nov; 26(11):980-4. PubMed ID: 17933488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 17beta-estradiol inhibits endothelin-1 production and attenuates cerebral vasospasm after experimental subarachnoid hemorrhage.
    Lin CL; Dumont AS; Wu SC; Wang CJ; Howng SL; Huang YF; Wong WY; Kassell NF; Jeng AY; Kwan AL
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1054-7. PubMed ID: 16741048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of disease: roles of nitric oxide and endothelin-1 in delayed cerebral vasospasm produced by aneurysmal subarachnoid hemorrhage.
    Suhardja A
    Nat Clin Pract Cardiovasc Med; 2004 Dec; 1(2):110-6; quiz 2 p following 116. PubMed ID: 16265315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Receptor changes in cerebral arteries after subarachnoid haemorrhage.
    Hansen-Schwartz J
    Acta Neurol Scand; 2004 Jan; 109(1):33-44. PubMed ID: 14653848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin and subarachnoid hemorrhage-induced cerebral vasospasm: pathogenesis and treatment.
    Lin CL; Jeng AY; Howng SL; Kwan AL
    Curr Med Chem; 2004 Jul; 11(13):1779-91. PubMed ID: 15279581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delayed ischemia after subarachnoid hemorrhage: result of vasospasm alone or a broader vasculopathy?
    Zemke D; Farooq MU; Mohammed Yahia A; Majid A
    Vasc Med; 2007 Aug; 12(3):243-9. PubMed ID: 17848485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.